. Author manuscript; available in PMC: 2010 Sep 8.

Published in final edited form as: Prostate. 2010 Mar 1;70(4):443–455. doi: 10.1002/pros.21078

TABLE II. Expression of Intracellular IL-10 and TGF-β1 by CD14⁺HLA-DR^low/− Cells and CD14⁺ HLA-DR⁺ Cells From Treated Prostate Cancer Patients (tPCa) and Age-Matched Controls.

Subject	HLA-DR^low/− cells, percent of CD14⁺ cells	IL-10 expressing cells			TGF-β1 expressing cells

		HLA-DR^low/− cells	HLA-DR⁺ cells	P-value^a	HLA-DR^low/− cells	HLA-DR⁺ cells	P-value^a
^b P27	14.0	90.4^c	73.4		43.6	33.6
P28	20.8	40.6	13.5		25.9	18.6
P29	24.3	89.2	69.0	0.0244	44.3	41.2	0.5405
A18	1.7	70.0	13.8		8.8	15.7
A19	5.0	40.4	26.4		47.2	50.2

Two-sided values calculated by paired Student's t-test for paired samples.

P denotes tPCa patients, A the age-matched controls (both indicated by ** in Supplementary Table I).

Percentage of CD14⁺HLA-DR^low/− cells and CD14⁺HLA-DR^high/+ cells, respectively, expressing IL-10 or TGF-β1.

TABLE II. Expression of Intracellular IL-10 and TGF-β1 by CD14+HLA-DRlow/− Cells and CD14+ HLA-DR+ Cells From Treated Prostate Cancer Patients (tPCa) and Age-Matched Controls.